Certification Rate
98.5%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2024. Review the filing volume, DOL certification record, and offered-wage context below.
Cambridge, MA NAICS: 541714
U.S. Department of Labor's OFLC discloses 66 Labor Condition Application filings naming Intellia Therapeutics from FY2023 through FY2024, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 194 H-1B petitions naming Intellia Therapeutics through FY2024, and approved nearly every one of them: 98.5% approved (191 approvals, 3 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Intellia Therapeutics is listed in 66 DOL LCA filings, more filings than 97% of employer filers in this extract. DOL certified 98.5% of those LCAs; the median listed offered wage is $127,105. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2024). Based in Cambridge, MA.
Intellia Therapeutics LCA outcome mix
66DOL LCA filings on record
Intellia Therapeutics vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
66 4023rd of 122824 higher than 118,801 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2024
Derived from this employer's disclosed LCAs on file (FY2023–FY2024), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $84,000–$195,000 .
DOL LCA release change
On 66 LCAs with comparable offered vs prevailing wages, Intellia Therapeutics averages about 13.1% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (39.4% of LCA filings).
This record covers filings made under the exact name "Intellia Therapeutics", which ran 65 in FY2023 and 1 in FY2024. Over the same years, a closely related name moved the opposite way:
The Labor Department indexes each filing by the employer name typed on it, so a company that re-cases its name, drops a "The", or adds a trading name starts a separate record mid-history. Because that is the likelier explanation here, this page does not state a filing trend for its own record alone. Read the records together.
Only 66 LCAs on file for Intellia Therapeutics, and 100% land in CAMBRIDGE CITY, MA. Treat rates as descriptive of a small sample. DOL cert on file: 98.5%.
Certification Rate
98.5%
Very high DOL cert
Avg. Salary
$127,105
Above portal avg
Total Workers
66
Moderate worker count
Compensation range for H-1B positions at Intellia Therapeutics
Wage vs. DOL Minimum
+13.1%
At/above DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
39.4% of LCA filings
Full-Time Positions
100%
Primary Worksite County
CAMBRIDGE CITY, MA
100% of LCA filings
Most frequently listed job titles at Intellia Therapeutics
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Scientist | 7 | $130,971 |
| Senior Research Associate | 6 | $88,700 |
| Associate Scientist | 6 | $100,483 |
| Senior Associate Scientist | 5 | $119,969 |
| Principal Scientist | 5 | $161,380 |
| Senior Research Associate, AAV Process Development | 3 | $90,400 |
| Senior Scientist | 2 | $146,225 |
| Senior Manager, Regulatory Affairs | 2 | $170,000 |
| Senior Associate | 2 | $122,000 |
| Scientist, Analytical Development | 2 | $135,000 |
| Computational Scientist | 2 | $135,000 |
| Associate Scientist, Analytical Development | 2 | $113,500 |
| Associate Director, Regulatory Affairs CMC | 2 | $195,000 |
| Software Engineer II , Data Engineering | 1 | $124,000 |
| Software Engineer I | 1 | $100,000 |
Cross-state DOL neighbors for Intellia Therapeutics - LCA filing-count and offered-wage axes, outside MA.
Nearest cross-state employer filers by LCA filing count (66 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($127,105 here).
Intellia Therapeutics is listed in 66 DOL Labor Condition Application filings covering 66 listed worker positions from FY2023 to FY2024. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Intellia Therapeutics ranks #3971 by total LCA filing count (66 filings). 118,801 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Intellia Therapeutics has a 98.5% DOL certification rate, with 65 out of 66 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Intellia Therapeutics's LCAs is $127,105. Listed wages range from $84,000 to $195,000 and are not verified actual compensation.
The top job titles in Intellia Therapeutics's LCA filing records include Scientist, Senior Research Associate, Associate Scientist. The most common listed title is Scientist with 7 LCA filings at an average listed offered wage of $130,971. This does not establish actual job openings, hiring, or approved petitions.
Intellia Therapeutics is headquartered in Cambridge, MA.
No, Intellia Therapeutics is not classified as H-1B dependent.
Intellia Therapeutics is listed in 65 LCA filings in FY2023 and 1 in FY2024. The average listed offered wage increased from $126,829 to $145,000. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 66 LCAs (Δ 0 heavier vs Intellia Therapeutics); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 66 LCAs (Δ 0 heavier vs Intellia Therapeutics); CERT-CLEAN · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 66 LCAs (Δ 0 heavier vs Intellia Therapeutics); CERT-SOLID · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 66 LCAs (Δ 0 heavier vs Intellia Therapeutics); CERT-CLEAN · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-CLEAN · WAGE-PREMIUM.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Intellia Therapeutics's MICRO-BOOK.
Open the MA state board after the ABS peers. Intellia Therapeutics stamps MICRO-BOOK · CERT-CLEAN inside that worksite mix.
Intellia Therapeutics's WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Intellia Therapeutics to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.